Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression. - Vitorino P; Chuang CH; Iannello A; Zhao X; Anderson W; Ferrando R; Zhang Z; Madhavan S; Karsunky H; Saunders LR (Translational oncology, 2021)